Ginseng and obesity: Observations from assorted perspectives

Food Science and Biotechnology

Volumn 23, Issue 4, 2014, Pages 1007-1016

  Siraj, Fayeza Md ^a   Kim, Yeon Ju ^a   Natarajan, Sathishkumar ^a   Jung, Seok Kyu ^a   Yang, Dong Uk ^a   Yang, Deok Chun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

adipocyte; ginsenosides; obesity; Panax ginseng

Indexed keywords

MOLECULAR WEIGHT; NUTRITION; PHARMACODYNAMICS;

ADIPOCYTES; BENEFICIAL EFFECTS; CLINICAL TRIAL; CRUDE EXTRACT; GINSENG SAPONINS; GINSENOSIDES; OBESITY; PANAX GINSENG;

DISEASES;

EID: 84905443825     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-014-0137-x     Document Type: Review

References (63)

1. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol. Rev. 78: 783-809 (1998).
2. Gregoire FM. Adipocyte differentiation: From fibroblast toendocrine cell. Exp. Biol. Med. 226: 997-1002 (2001).
3. Nawrocki AR, Scherer PE. Keynote review: The adipocyte as a drug discovery target. Drug Discov. Today 10: 1219-1230 (2005).
4. Mahalia SD, Nagajyothi, Maria ET, Herbert BT, Philipp ES. Adipocyte, adipose tissue and infectious disease. Infect. Immun. 75: 1066-1078 (2007).
5. Bays H, Mandarino L, Defronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J. Clin. Endocr. Metab. 89: 463-478 (2004).
6. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768-780 (2003).
7. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693 (1999).
8. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern. Med. Rev. 9: 259-274 (2004).
9. Xie JT, Wang CZ, Wang AB, Wu J, Basila D, Yuan CS. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol. Sin. 26: 1104-1110 (2005).
10. Chung SH, Choi CG, Park SH. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch. Pharm. Res. 24: 214-218 (2001).
11. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocr. Metab. 89: 2548-2556 (2004).
12. Cannon B, Nedergaard J. Developmental biology: Neither fat nor flesh. Nature 454: 947-948 (2008).
13. Stephane G, Ronald KC. White adipose tissue. Adipose Tissue Biol. 4: 71-121 (2012).
14. Frontini A, Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab. 11: 253-256 (2010).
15. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. New Engl. J. Med. 34: 427-434 (1999).
16. Ardern CI, Katzmarzyk PT, Janssen I, Ross R. Discrimination of health risk by combined body mass index and waist circumference. Obes. Res. 11: 135-142 (2003).
17. Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardio metabolic risk factors? Diabetes Care 30: 3105-3109 (2007).
18. Meisinger C, Doring A, Thorand B, Heier M, Lowel H. Body fat distribution and risk of type 2 diabetes in the general population: Are there differences between men and women? The monica/kora augsburg cohort study. Am. J. Clin. Nutr. 84: 483-489 (2006).
19. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4: 611-617 (1999).
20. El-Jack AK, Hamm JK, Pilch PF, Farmer SR. Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARγ and C/EBPα. J. Biol. Chem. 274: 7946-7951 (1999).
21. Wu Z, Rosen ED, Brun R, Hauser S, Adelmont G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3: 151-158 (1999).
22. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrin. Met. 20: 107-114 (2009).
23. Hwang CS, Loftus TM, Mandrup S, Lane MD. Adipocyte differentiation and leptin expression. Ann. Rev. Cell Dev. Bi. 13: 231-259 (1997).
24. Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Bio. 7: 885-896 (2006).
25. David GP, Chia RY, Wei Z. Ginsenosides derived from Asian (Panax Ginseng), American ginseng (Panax quinquefolius) and potential cytoactivity. Intl. J. Biomed. Pharma. Sci. 6: 56-62 (2011).
26. Zhanxiang W, Hongji Z. Antidiabetic effects of ginseng in humans and rodents. J. Metabolic Synd. 1: 1-7 (2012).
27. James MN, Young CK. Adipocyte differentiation and gene expression. J. Nutr. 130: 3122S-3126S (2000).
28. Evan DR, Christopher JW, Pere P, Bruce MS. Transcriptional regulation of adipogenesis. Gene. Dev. 14: 1293-1307 (2000).
29. Han KL, Jung MH, Sohn JH, Hwang JK. Ginsenoside 20(S)-protopanaxatriol (PPT) activates peroxisome proliferator activated receptor gamma (PPARγ) in 3T3-L1 adipocytes. Biol. Pharm. Bull. 29: 110-113 (2006).
30. Wenbin S, Ying Y, Boren J, Hua J, Libin Z, Shangquan L, Mingdao C. Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARγ2 and C/EBPα gene expression. Life Sci. 80: 618-625 (2007).
31. Kim EJ, Lee HI, Chung KJ, Noh YH, Ro Y, Koo JH. The ginsenoside-Rb2 lowers cholesterol and triacylglycerol levels in 3T3-L1 adipocytes cultured under high cholesterol or fatty acids conditions. BMB Rep. 42: 194-199 (2009).
32. Kim SN, Lee JH, Shin H, Son SH, Kim YS. Effects of in vitrodigested ginsenosides on lipid accumulation in 3T3-L1 adipocytes. Planta Med. 75: 596-601 (2009).
33. Chia RY, Chen Y, Ting YW, David G. A quantified ginseng (Panax ginseng C. A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules 16: 477-492 (2011).
34. Niu CS, Yeh CH, Yeh MF, Cheng JT. Increase of adipogenesis by ginsenoside (Rh2) in 3T3-L1 cell via an activation of glucocorticoid receptor. Horm. Metab. Res. 41: 271-276 (2009).
35. Park S, Ahn IS, Kwon DY, Ko BS, Jun WK. Ginsenosides Rb1 and Rg1 suppress triglyceride accumulation in 3T3-L1 adipocytes and enhance β-cell insulin secretion and viability in Min6 cells via PKA-dependent pathways. Biosci. Biotech. Bioch. 72: 2815-2823 (2008).
36. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, Kim HS, Ha J, Kim MS, Kwon DY. Anti-obesity eects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem. Bioph. Res. Co. 364: 1002-1008 (2007).
37. Mohammad LM, Yong PC, Jun GI, Deok CY, Young CK, Jae CS, Kil SK. Inhibitory effects of cultivated wild ginseng on the differentiation of 3T3-L1 pre-adipocytes. J. Ginseng Res. 35: 45-51 (2011).
38. Hwang JT, Lee MS, Sung MJ, Kim HY, Kim MS, Kwon DY. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR signal pathways. Phytother. Res. 23: 262-266 (2009).
39. Kim MS, Lee MS, Kim SH, Kim HJ, Sung MJ, Kim HY, Kwon DY, Hwang JT. Anti-obesity effects of ginsenoside Rd via AMPK and PPAR gamma. Korean J. Biotechnol. Bioeng. 22: 341-344 (2007).
40. Wan G, Kyung AK, Dong HK. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation. Biol. Pharm. Bull. 36: 102-107 (2013).
41. Dongmin P, Michung Y. Compound K, a novel ginsenoside metabolite, inhibits adipocyte differentiation in 3T3-L1 cells: Involvement of angiogenesis and MMPs. Biochem. Bioph. Res. Co. 422: 263-267 (2012).
42. Kwon DH, Bose S, Song MY, Lee MJ, Lim CY, Kwon BS, Kim HJ. Efficacy of Korean red ginseng by single nucleotide polymorphism in obese women: Randomized, double-blind placebo-controlled trial. J. Ginseng Res. 36: 176-189 (2012).
43. Lee YS, Cha BY, Yamaguchi K, Choi SS, Yonezawa T, Teruya T, Nagai K, Woo JT. Effects of Korean white ginseng extracts on obesity in high fat diet-induced obese mice. Cytotechnology 62: 367-376 (2010).
44. Mollah ML, Kim GS, Moon HK, Chung SK, Cheon YP, Kim JK, Kim KS. Anti-obesity effects of wild ginseng (Panax ginseng C. A. Meyer) mediated by PPAR-γ, GLUT4 and LPL in ob/ob mice. Phytother. Res. 23: 220-225 (2009).
45. Woo HC, Shin BK, Cho IJ, Koo HN, Kim MH, Han JH. Antiobesity effect of carbon dioxide supercritical fluid extracts of Panax ginseng C. A. Meyer. J. Korean Soc. Appl. Biol. Chem. 54: 738-743 (2011).
46. Kim HJ, Kang HJ, Seo JY, Lee CH, Kim YS, Kim JS. Antiobesity effect of oil extract of ginseng. J. Med. Food 14: 573-583 (2011).
47. Xie JT, Zhou YP, Dey L, Attele AS, Wu JA, Gu M, Polonsky KS, Yuan CS. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9: 254-258 (2002).
48. Kim JH, Hahm DH, Yang DC, Kim JH, Lee HJ, Shim I. Effect of crude saponin of Korean red ginseng on high fat diet induced obesity in the rat. J. Pharmacol. Sci. 97: 124-131 (2005).
49. Kim JH, Kang SA, Han SM, Shim I. Comparison of the antiobesity effects of the protopanaxadiol and protopanaxatriol type saponins of red ginseng. Phytother. Res. 23: 78-85 (2009).
50. Song YB, An YR, Kim SJ, Park HW, Jung JW, Kyung JS, Hwang SY, Kim YS. Lipid metabolic effect of Korean red ginseng extract in mice fed on a high-fat diet. J. Sci. Food Agr. 92: 388-396 (2012).
51. Yun SN, Moon SJ, Ko SK, Im BO, Chung SH. Wild ginseng prevents the onset of high fat diet induced hyperglycemia and obesity in ICR mice. Arch. Pharm. Res. 27: 790-796 (2004).
52. Karu N, Reifen R, Kerem Z. Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor. J. Agr. Food Chem. 55: 2824-2828 (2007).
53. Ye X, Ling S, Kristina JL, Patrick T, Yuqing X, Guangji W, Stephen CW, Min L. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 59: 2505-2512 (2010).
54. Park MY, Lee KS, Sung MK. Effects of dietary mulberry, Korean red ginseng, and banaba on glucose homeostasis in relation to PPAR-α, PPAR-γ, and LPL mRNA expressions. Life Sci. 77: 3344-3354 (2005).
55. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y. PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: Mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52: 291-299 (2003).
56. Yeo CR, Lee SM, Popovich DG. Ginseng (Panax quinquefolius) reduces cell growth, lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Evid-Based Compl. Alt. 2011: 1-9 (2011).
57. Liu W, Zheng Y, Han L, Wang H, Saito M, Ling M, Kimura Y, Feng Y. Saponins (Ginsenosides) from stems and leaves of Panax quinquefolium prevented high fat diet induced obesity in mice. Phytomedicine 15: 1140-1145 (2008).
58. Rui L, Jing ZZ, Wen CL, Yoshiyuki K, Yi NZ. Anti-obesity effects of protopanaxdiol types of ginsenosides isolated from the leaves of American ginseng (Panaxquinquefolius L.) in mice fed with a highfat diet. Fitoterapia 81: 1079-1087 (2010).
59. Xie JT, Wang CZ, Ni M, Wu JA, Mehendale SR, Aung HH, Foo A, Yuan C. S. American ginseng berry juice intake reduces blood glucose and body weight in ob/ob Mice. J. Food Sci. 72: S590-S594 (2007).
60. Yang CY, Xie ZG, Cheng WB, Jiang X, Chen ZH. Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice. Zhong. Yao. Cai. 32: 1571-1576 (2009).
61. Hong SJ, Fong JC, Hwang JH. Effects of crude drugs on lipolysis in differentiated 3T3-L1 adipocytes. Kaohsiung J. Med. Sci. 18: 157-163 (2002).
62. Philip AK, Gina DG, Tong L, Negah R, Gouri R. Perilipin expression in human adipose tissue is elevated with obesity. J. Clin. Endocr. Metab. 89: 1352-1358 (2004).
63. Yumiko O, Ichiro M, Kazuyuki T, Kensuke T, Takayuki S, Katsuhito F, Go N, Koji M, Toshimasa Y, Naoto K, Ryo S, Toshio K, Shizuo A, Takashi K, Ryozo N. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1: 27-39 (2005).